Epigenetic analyses in blood cells of men suspected of prostate cancer predict the outcome of biopsy better than serum PSA levels

Clinical Epigenetics

Volumn 2, Issue 2, 2011, Pages 383-388

  Cytron, Samuel ^a   Stepnov, Evgeni ^a   Bounkin, Igor ^a   Mashevich, Maya ^b   Dotan, Aviva ^b   Avivi, Lydia ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Asynchronous replication; Cancer biomarkers; FISH; Prostate cancer; PSA; Replication timing

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ALLELE; AML1 GENE; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL INDICATOR; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EPIGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REPLICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RB1 GENE; SENSITIVITY AND SPECIFICITY; TUMOR GENE;

EID: 84856275827     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1007/s13148-011-0029-3     Document Type: Article

References (27)

1. Amiel A, Kitay-Cohen Y, Fejgin MD, Lishner M (2000) Replication status as a marker for predisposition for lymphoma in patients with chronic hepatitis C with and without cryoglobulinemia. Exp Hematol 28:156-160 (Pubitemid 30100822)
2. Amiel A, Elis A, Blumenthal D, Gaber E, Fejgin MD, Dubinsky R, Lishner M (2001a) Modified order of allelic replication in lymphoma patients at different disease stages. Cancer Genet Cytogenet 125:156-160 (Pubitemid 32448061)
3. Amiel A, Elis A, Sherker S, Gaber E, Manor Y, Fejgin MD (2001b) The influence of cytogenetic aberrations on gene replication in chronic lymphocytic leukemia patients. Cancer Genet Cytogenet 125:81-86 (Pubitemid 32451681)
4. Applewhite JC, Matagla BR, McCullough D (2002) Results of the 5 region prostate biopsy method: the repeat biopsy population. J Urol 168:500-503 (Pubitemid 34793281)
5. Boggs BA, Chinault AC (1997) Analysis of DNA replication by fluorescence in situ hybridization. Methods 13:259-270
6. Brás A, Cotrim CZ, Vasconcelos I, Mexia J, Onard AL, Sanzhar I, Akhmatullina N, Rueff J (2008) Asynchronous DNA replication detected by fluorescence in situ hybridisation as a possible indicator of genetic damage in human lymphocytes. Oncol Rep 19:369-375 (Pubitemid 351176096)
7. Carter HB (2000) A PSA threshold of 4.0 ng/mL for early detection of prostate cancer: the only rational approach for men 50 years old and older. Urology 55:796-799 (Pubitemid 30330773)
8. Catalona W, Ramos CG, Carvalhal GF, Yan Y (2000) Lowering PSA cutoffs to enhance detection of curable prostate cancer. Urology 55:791-795 (Pubitemid 30330772)
9. Costa VL, Henrique R, Jeronimo C (2007) Epigenetic markers for molecular detection of prostate cancer. Dis Markers 23:31-41 (Pubitemid 46333639)
10. Dotan ZA, Dotan A, Litmanovitch T, Ramon J, Avivi L (2000) Modification in the inherent mode of allelic replication in lymphocytes of patients suffering from renal cell carcinoma: a novel genetic alteration associated with malignancy. Gene Chromosome Canc 27:270-277 (Pubitemid 30067456)
11. Dotan ZA, Dotan A, Ramon J, Avivi L (2004) Altered mode of allelic replication accompanied by aneuploidy in peripheral blood lymphocytes of prostate cancer patients. Int J Cancer 111:60-66 (Pubitemid 38859283)
12. Dotan ZA, Dotan A, Ramon J, Avivi L (2008) Aberrant allele-specific replication, independent of parental origin, in blood cells of cancer patients. BMC Cancer. doi:10.1186/1471-2407-8-390
13. Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J (2006) Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol 175:1605-1612
14. Ensminger AW, Chess A (2004) Coordinated replication timing of monoallelically expressed genes along human autosomes. Hum Mol Genet 13:651-658 (Pubitemid 38379854)
15. Goldmit M, Bergman Y (2004) Monoallelic gene expression: a repertoire of recurrent themes. Immunol Rev 200:197-214 (Pubitemid 38998203)
16. Grinberg-Rashi H, Cytron S, Gelman-Kohan Z, Litmanovitch T, Avivi L (2010) Replication timing aberrations and aneuploidy in peripheral blood lymphocytes of breast cancer patients. Neoplasia 12:668-674
17. Hankey BF, Feuer EJ, Clegg LX, Ries LA, Merrill RM, Kaplan RS (1999) Cancer surveillance series: interpreting trends in prostate cancer-part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst 91:1017-1024 (Pubitemid 29293040)
18. Harden SV, Sanderson H, Goodman SN, Sidransky D (2003) Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsies. J Natl Cancer Inst 95:1634-1637 (Pubitemid 37455931)
19. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71-96
20. Korenstein-Ilan A, Amiel A, Lalezari S, Lishner M, Avivi L (2002) Allele-specific replication associated with aneuploidy in blood cells of patients with hematologic malignancies. Cancer Genet Cytogenet 139:97-103 (Pubitemid 36110649)
21. Nagler A, Korenstein-Ilan A, Amiel A, Avivi L (2004) Granulocyte colony stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells. Exp Hematol 32:122-130 (Pubitemid 38064408)
22. Nagler A, Cytron S, Mashevich M, Korenstein-Ilan A, Avivi L (2010) The aberrant asynchronous replication-characterizing lymphocytes of patients with hematological malignancies-is erased following stem cell transplantation. BMC Cancer. doi:10.1186/1471-2407-10-230
23. Sakai T, Toguchida J, Ohtani N, Yandell DW, Rapaport JM, Dryja TP (1991) Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am J Hum Genet 48:880-888 (Pubitemid 21891632)
24. Smith RA, Cokkinides V, Brawley OW (2008) Cancer screening in the United States, 2008: a review of current American Cancer Society guidelines and cancer screening issues. CA Cancer J Clin 58:161-179 (Pubitemid 351830300)
25. Stamey TA, Caldwell M, McNeal JE, Nolley R, Hemenez M, Downs J (2004) The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J Urol 172:1297-1301 (Pubitemid 39249701)
26. Stott SL, Lee RJ, Nagrath S, Yu M, Miyamoto DT, Ulkus L, Inserra EJ, Ulman M, Springer S, Nakamura Z, Moore AL, Tsukrov DI, Kempner ME, Dahl DM, Wu C-L, Iafrate AJ, Smith MR, Tompkins RG, Sequist LV, Toner M, Haber DA, Maheswaran S (2010) Isolation and characterization of circulating tumor cells from patients with localize and metastatic prostate cancer. Sci Transl Med 2:25ra23
27. Zhang Y, Rowley JD (2006) Chromatin structural elements and chromosomal translocations in leukemia. DNA Repair (Amst) 5:1282-1297 (Pubitemid 44291613)